CHRIS VERRICO to Humans
This is a "connection" page, showing publications CHRIS VERRICO has written about Humans.
Connection Strength
0.252
-
Comorbid alcohol use and post-traumatic stress disorders: Pharmacotherapy with aldehyde dehydrogenase 2 inhibitors versus current agents. Prog Neuropsychopharmacol Biol Psychiatry. 2022 04 20; 115:110506.
Score: 0.021
-
A randomized trial of safety and pharmacodynamic interactions between a selective glucocorticoid receptor antagonist, PT150, and ethanol in healthy volunteers. Sci Rep. 2021 05 10; 11(1):9876.
Score: 0.020
-
Subtherapeutic Acetazolamide Doses as a Noninvasive Method for Assessing Medication Adherence. Clin Pharmacol Ther. 2020 12; 108(6):1203-1212.
Score: 0.019
-
Use of Guanfacine for Cannabis Use Disorder and Related Symptomology. Am J Addict. 2019 11; 28(6):455-464.
Score: 0.018
-
FAAH variant Pro129Thr modulates subjective effects produced by cocaine administration. Am J Addict. 2018 10; 27(7):567-573.
Score: 0.017
-
Guanfacine Attenuates Adverse Effects of Dronabinol (THC) on Working Memory in Adolescent-Onset Heavy Cannabis Users: A Pilot Study. J Neuropsychiatry Clin Neurosci. 2018; 30(1):66-76.
Score: 0.015
-
Subjective and Cardiovascular Effects of Intravenous Methamphetamine during Perindopril Maintenance: A Randomized, Double-Blind, Placebo-Controlled Human Laboratory Study. Int J Neuropsychopharmacol. 2016 07; 19(7).
Score: 0.014
-
Treatment with modafinil and escitalopram, alone and in combination, on cocaine-induced effects: a randomized, double blind, placebo-controlled human laboratory study. Drug Alcohol Depend. 2014 Aug 01; 141:72-8.
Score: 0.012
-
Safety and efficacy of varenicline to reduce positive subjective effects produced by methamphetamine in methamphetamine-dependent volunteers. Int J Neuropsychopharmacol. 2014 Feb; 17(2):223-33.
Score: 0.012
-
Pharmacotherapeutics for substance-use disorders: a focus on dopaminergic medications. Expert Opin Investig Drugs. 2013 Dec; 22(12):1549-68.
Score: 0.012
-
MDMA (Ecstasy) and human dopamine, norepinephrine, and serotonin transporters: implications for MDMA-induced neurotoxicity and treatment. Psychopharmacology (Berl). 2007 Jan; 189(4):489-503.
Score: 0.007
-
Exenatide as an adjunct to nicotine patch for smoking cessation and prevention of postcessation weight gain among treatment-seeking smokers with pre-diabetes and/or overweight: study protocol for a randomised, placebo-controlled clinical trial. BMJ Open. 2023 06 14; 13(6):e072707.
Score: 0.006
-
Neurocognitive Correlates of Cerebellar Volumetric Alterations in Youth with Pediatric Bipolar Spectrum Disorders and Bipolar Offspring. Curr Neuropharmacol. 2023; 21(6):1367-1378.
Score: 0.006
-
Continuing the conversation around opioid use disorder and post-traumatic stress disorder comorbidity. Lancet Psychiatry. 2022 08; 9(8):e37-e38.
Score: 0.005
-
Neurocircuitry basis of the opioid use disorder-post-traumatic stress disorder comorbid state: conceptual analyses using a dimensional framework. Lancet Psychiatry. 2022 01; 9(1):84-96.
Score: 0.005
-
Exenatide Adjunct to Nicotine Patch Facilitates Smoking Cessation and May Reduce Post-Cessation Weight Gain: A Pilot Randomized Controlled Trial. Nicotine Tob Res. 2021 08 29; 23(10):1682-1690.
Score: 0.005
-
Suicidal behaviors and attention deficit hyperactivity disorder (ADHD): a cross-sectional study among Chinese medical college students. BMC Psychiatry. 2021 05 18; 21(1):258.
Score: 0.005
-
Cognitive correlates of impulsive aggression in youth with pediatric bipolar disorder and bipolar offspring. J Affect Disord. 2021 05 15; 287:387-396.
Score: 0.005
-
An Evaluation of Yoga and Meditation to Improve Attention, Hyperactivity, and Stress in High-School Students. J Altern Complement Med. 2020 Aug; 26(8):701-707.
Score: 0.005
-
Rivastigmine does not alter cocaine-induced subjective effects or self-administration. Pharmacol Biochem Behav. 2019 10; 185:172758.
Score: 0.004
-
The prevalence, metabolic disturbances and clinical correlates of recent suicide attempts in Chinese inpatients with major depressive disorder. BMC Psychiatry. 2019 05 10; 19(1):144.
Score: 0.004
-
Psychosis and synthetic cannabinoids. Psychiatry Res. 2018 10; 268:400-412.
Score: 0.004
-
Doxazosin XL reduces symptoms of posttraumatic stress disorder in veterans with PTSD: a pilot clinical trial. J Clin Psychiatry. 2016 May; 77(5):e561-5.
Score: 0.004
-
Safety and Preliminary Efficacy of the Acetylcholinesterase Inhibitor Huperzine A as a Treatment for Cocaine Use Disorder. Int J Neuropsychopharmacol. 2015 Sep 12; 19(3):pyv098.
Score: 0.003
-
Dopamine D3 receptor-preferring agonist enhances the subjective effects of cocaine in humans. Psychiatry Res. 2015 Nov 30; 230(1):44-9.
Score: 0.003
-
A comparison of impulsivity, depressive symptoms, lifetime stress and sensation seeking in healthy controls versus participants with cocaine or methamphetamine use disorders. J Psychopharmacol. 2015 Jan; 29(1):50-6.
Score: 0.003
-
Short-term, low-dose varenicline administration enhances information processing speed in methamphetamine-dependent users. Neuropharmacology. 2014 Oct; 85:493-8.
Score: 0.003
-
The relationship between sleep and drug use characteristics in participants with cocaine or methamphetamine use disorders. Psychiatry Res. 2014 Oct 30; 219(2):367-71.
Score: 0.003
-
Preliminary findings of the effects of rivastigmine, an acetylcholinesterase inhibitor, on working memory in cocaine-dependent volunteers. Prog Neuropsychopharmacol Biol Psychiatry. 2014 Apr 03; 50:137-42.
Score: 0.003
-
Endocannabinoid metabolism in the prefrontal cortex in schizophrenia. Schizophr Res. 2013 Jun; 147(1):53-57.
Score: 0.003
-
Cannabinoid CB1 receptor immunoreactivity in the prefrontal cortex: Comparison of schizophrenia and major depressive disorder. Neuropsychopharmacology. 2010 Sep; 35(10):2060-71.
Score: 0.002
-
Primate trace amine receptor 1 modulation by the dopamine transporter. J Pharmacol Exp Ther. 2005 Jun; 313(3):983-94.
Score: 0.002